SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

update

Biotrial criticised over fatal Phase I study by France's social affairs inspectorate

French investigators reviewing the Phase I trial in which one volunteer died and five others were hospitalized in January have criticised CRO Biotrial over how it conducted the study.

Olon SpA to buy Infa Group

Italian API firm Olon SpA has signed a definitive agreement to buy Infa Group in a deal designed to strengthen its portfolio.

IMA: Angina drug API firm JP Laboratories cannot keep Daund plant up to code

Indian API maker JP Laboratories is unable to sustain GMP compliance at its facility in Daund, Maharashtra according to the Italian Medicines Agency (IMA).

Italian regulator slams simvastatin-maker Krebs for GMP deviations

APIs made by Krebs Biochemicals and Industries at its facility in Visakhapatnam, India pose a ‘critical risk’ to public health according to Italian regulators.

Glide begins solid dose, injectable acromegaly drug trial on birthday of most famous sufferer

A solid dose version of the acromegaly treatment octreotide developed by Glide Technologies has entered a proof-of-concept study.

New technique creates 'nearly pure drug' for injection

Researchers have developed an “easy-to-adopt” process for removing excess additives from injectable drugs.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...